Figure 1.

miR-137 expression in HCC. (A) RT-qPCR was used to examine miR-137 expression in HCC tissues compared with adjacent non-tumor tissues. **P<0.01 vs. adjacent. (B) RT-qPCR was used to examine miR-137 expression in stage III–IV HCC tissues compared with stage I–II HCC tissues. **P<0.01 vs. stage I–II. (C) Patients with HCC with low miR-137 expression had shorter survival time, when compared with those with high expression of miR-137. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; miR, microRNA; HCC, hepatocellular carcinoma.